{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:16:58Z","timestamp":1794043018432,"version":"4.8.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>A quasi-experimental study was conducted to investigate the clinical efficacy and outcomes of calcitriol combined with bisphosphonates in the treatment of postmenopausal osteoporosis (OP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 152 patients with postmenopausal OP from March 2019 to June 2021 were enrolled. The patients who received calcitriol treatment were adopted as the control group, and the patients treated with calcitriol combined with bisphosphonates were considered as the intervention group. The treatment effects of patients were compared, and the pain degree of the joints of the patients was evaluated by Visual Analogue Scale\/Score (VAS), the Barthel Index score was used to evaluate the daily living ability of patients, the hand and Oswestry Disability Index (ODI) were used to evaluate the dysfunction before and after treatment, and the bone metabolism indexes, immune cytokines and bone mineral density were detected before and after treatment, and the incidence of adverse reactions was calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Regarding the therapeutic effects, the intervention group indicated an effective rate of 96.05% while the effective rate was 84.21% in the control group. The total effective rate of treatment in the intervention group was higher than the control group. The VAS, ODI scores, and bone metabolism indexes of the intervention group were significantly lower than the control group at 1, 2, and 3 months after treatment. The Barthel Index scores and bone mineral density of the intervention group were higher than the control group at 1, 2, and 3 months after treatment. The improvement of immune cytokines in the intervention group was significantly better than the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). One patient in the intervention group developed dizziness and 1 patient developed chills, with an adverse reaction rate of 2.63%, while in the control group, 2 patients had fever, and 2 patients developed chills, with an adverse reaction rate of 5.26% (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Calcitriol combined with bisphosphonates has a significant clinical effect in the treatment of postmenopausal OP, which can significantly relieve bone pain in postmenopausal OP patients, enhance abnormal bone metabolism and immune function, and promote bone mineral density and daily living ability.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040171","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T20:00:28Z","timestamp":1731355228000},"page":"e40171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Clinical efficacy and outcomes of calcitriol combined with bisphosphonates in the treatment of postmenopausal osteoporosis: A quasi-experimental study"],"prefix":"10.1097","volume":"103","author":[{"given":"Kui","family":"Han","sequence":"first","affiliation":[{"name":"General Practice Department, Shanghai Changfeng Community Health Service Center of Putuo District, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4625-4927","authenticated-orcid":false,"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"General Practice Department, Shanghai Changfeng Community Health Service Center of Putuo District, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of OP.","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"R2-20250504","first-page":"92","article-title":"OP: a review of treatment options.","volume":"43","author":"Tu","year":"2018","journal-title":"P&T"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0038-1660790","article-title":"OP: current concepts.","volume":"6","author":"Akkawi","year":"2018","journal-title":"Joints"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"OP treatment: recent developments and ongoing challenges.","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/17425255.2016.1175436","article-title":"Pharmacodynamics and pharmacokinetics of oral salmoncalcitonin in the treatment of OP.","volume":"12","author":"Bandeira","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R6-20250504","first-page":"40","article-title":"Application of quantitative CT bone mineral density measurement in middle-aged and elderly men.","volume":"27","author":"Li","year":"2021","journal-title":"Chin J OP"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"382","DOI":"10.14740\/jocmr2970w","article-title":"Gender disparities in OP.","volume":"9","author":"Alswat","year":"2017","journal-title":"J Clin Med Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jama.2017.21995","article-title":"Treatment of OP.","volume":"319","author":"Cotts","year":"2018","journal-title":"JAMA"},{"key":"R9-20250504","first-page":"11","article-title":"Factors related with OP treatment inpostmenopausal women.","volume":"2","author":"Rossi","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R10-20250504","first-page":"316","article-title":"Guidelines for primary OP diagnosis and treatment (practical edition 2019).","volume":"04","year":"2020","journal-title":"Chin J Gen Pract"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3889\/oamjms.2019.473","article-title":"Correlation between visual analogue scale score and hospital anxiety depression scale-depression score in patients with cervical cancer in the Hospital Vina Cancer, Medan.","volume":"7","author":"Widyastuty","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.11005\/jbm.2017.24.3.187","article-title":"Quality of life in patients with osteoporotic vertebral compression fractures.","volume":"24","author":"Jung","year":"2017","journal-title":"J Bone Metab"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40520-017-0809-5","article-title":"Psychometric characteristics of the Spanish version of the Barthel Index.","volume":"30","author":"Gonz\u00e1lez","year":"2018","journal-title":"Aging Clin Exp Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00266-021-02426-w","article-title":"Evaluation of efficacy of corticosteroid and corticosteroid combined with botulinum toxin type a in the therapy of keloid and hypertrophic scars: a meta-decomposition.","volume":"45","author":"Liu","year":"2021","journal-title":"Aesthetic Plast Surg"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e16234","DOI":"10.1097\/MD.0000000000016234","article-title":"A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients.","volume":"98","author":"Guo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R16-20250504","first-page":"206","article-title":"The effect of zoledronate sodium combined with calcitriol in the treatment of primary osteoporosis.","volume":"5","author":"Yuhang","year":"2019","journal-title":"Chin Electronic J Geriatr Orthop Rehab"},{"key":"R17-20250504","first-page":"35","article-title":"Efficacy of calcitriol in the therapy of hyperthyroid osteoporosis and its effect on OPG and RANKL standards.","volume":"3","author":"Hu","year":"2018","journal-title":"Clin Res Pract"},{"key":"R18-20250504","first-page":"825","article-title":"Efficacy of calcitriol combined with risedronate in the therapy of postmenopausal osteoporosis.","volume":"16","author":"Jiang","year":"2019","journal-title":"Renren Health"},{"key":"R19-20250504","first-page":"994","article-title":"Epidemiological investigation of senile osteoporosis and research on preventive measures.","volume":"25","author":"Zhao Zongquan","year":"2019","journal-title":"Chin J Osteop"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"6053410","DOI":"10.1155\/2022\/6053410","article-title":"Combination of calcitriol and zoledronic acid on PINP and \u03b2-CTX in postoperative patients with diabetic osteoporosis: a randomized controlled trial.","volume":"2022","author":"Hu","year":"2022","journal-title":"Dis Markers"},{"key":"R21-20250504","first-page":"1","article-title":"Meta-decomposition of clinical efficacy and safety of Tripterygium wilfordii polyglycosides tablets in the therapy of chronic kidney ailment.","volume":"2021","author":"Guo","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1507\/endocrj.EJ12-0283","article-title":"Efficacy of a combined alendronate and calcitriol agent (Maxmarvil\u00ae) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study.","volume":"60","author":"Rhee","year":"2013","journal-title":"Endocr J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1749-799X-3-51","article-title":"Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats.","volume":"3","author":"Nakamura","year":"2008","journal-title":"J Orthop Surg Res"},{"key":"R24-20250504","first-page":"93","article-title":"Clinical effectiveness of calcitriol and calcium gluconate in treating older male patients with osteoporosis.","volume":"20","author":"Zhang","year":"2024","journal-title":"J Men Health"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jnen\/63.4.381","article-title":"IL-1 and TNF-\u03b1 play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess.","volume":"63","author":"Kielian","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/107999000750053744","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1)-induced and interleukin-1\u03b2 (IL-1\u03b2)-induced shedding of TNF receptors from gingival fibroblasts.","volume":"20","author":"Ohe","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00281-006-0012-9","article-title":"Inhibition of IL-1, IL-6, and TNF-\u03b1 in immune-mediated inflammatory diseases.","volume":"27","author":"M\u00f6ller","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology.","volume":"15","author":"Steeve","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"R29-20250504","first-page":"85","article-title":"Effect of bisphosphonates combined with calcitriol on bone mineral density of patients with osteoporosis due to endocrine therapy for breast cancer.","volume":"25","author":"Yan","year":"2021","journal-title":"J Clin Med Pract"},{"key":"R30-20250504","first-page":"2371","article-title":"The curative effect of the additional administration of ibandronate sodium and calcitriol on elderly patients with osteoporosis.","volume":"13","author":"Zhang","year":"2020","journal-title":"Int J Clin Exp Med"},{"key":"R31-20250504","first-page":"259","article-title":"Evaluation of the efficacy and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment.","volume":"55","author":"Yan","year":"2019","journal-title":"Chin J Ophthalmol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4082\/kjfm.2012.33.6.346","article-title":"The efficacy and safety of a combined alendronate and calcitriol agent (maxmarvil): a postmarketing surveillance study in Korean postmenopausal women with osteoporosis.","volume":"33","author":"Suh","year":"2012","journal-title":"Korean J Fam Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:00:23Z","timestamp":1746320423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":32,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040171","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}